RxSight Inc.

NASDAQ: RXST · Real-Time Price · USD
8.41
0.19 (2.31%)
At close: Aug 15, 2025, 2:35 PM

RxSight Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-27.45M -48.61M -66.76M -48.69M
Depreciation & Amortization
3.62M 4.24M 4.02M 3.99M
Stock-Based Compensation
24.64M 15.75M 11.4M 7.58M
Other Working Capital
4.64M 1.75M 5.6M 874K
Other Non-Cash Items
-8.54M -3.9M -101K 493K
Deferred Income Tax
n/a n/a n/a -5.4M
Change in Working Capital
-9.21M -9.07M -7.41M -2.68M
Operating Cash Flow
-16.95M -41.59M -58.85M -44.71M
Capital Expenditures
-5.44M -4.81M -2.39M -1.94M
Cash Acquisitions
n/a 17.32M -42.34M 79.97M
Purchase of Investments
n/a -272.31M -212.66M -159.97M
Sales Maturities Of Investments
n/a 255M 255M 80M
Other Investing Acitivies
-99.31M -17.32M 42.34M -79.97M
Investing Cash Flow
-99.31M -22.13M 39.95M -81.91M
Debt Repayment
-61K -40.15M -121K 14.97M
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-5.54M -4.28M -1.38M 1.23M
Financial Cash Flow
123.32M 61.52M 6.33M 137.34M
Net Cash Flow
7.05M -2.19M -12.58M 10.72M
Free Cash Flow
-22.39M -46.41M -61.24M -46.65M